Ungaro F - Search Results

1

Antistaphylococcal Activity of the FtsZ Inhibitor C109.

Trespidi G, Scoffone VC, Barbieri G, Marchesini F, Abualsha'ar A, Coenye T, Ungaro F, Makarov V, Migliavacca R, De Rossi E, Buroni S. Trespidi G, et al. Among authors: ungaro f. Pathogens. 2021 Jul 13;10(7):886. doi: 10.3390/pathogens10070886. Pathogens. 2021. PMID: 34358036 Free PMC article.

2

PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection.

Costabile G, Provenzano R, Azzalin A, Scoffone VC, Chiarelli LR, Rondelli V, Grillo I, Zinn T, Lepioshkin A, Savina S, Miro A, Quaglia F, Makarov V, Coenye T, Brocca P, Riccardi G, Buroni S, Ungaro F. Costabile G, et al. Among authors: ungaro f. Nanomedicine. 2020 Jan;23:102113. doi: 10.1016/j.nano.2019.102113. Epub 2019 Oct 25. Nanomedicine. 2020. PMID: 31669084 Free article.

3

Alcohol-Based Hand Sanitizers: Does Gelling Agent Really Matter?

d'Angelo I, Provenzano R, Florio E, Pagliuca C, Mantova G, Scaglione E, Vitiello M, Colicchio R, Salvatore P, Ungaro F, Quaglia F, Miro A. d'Angelo I, et al. Among authors: ungaro f. Gels. 2022 Jan 29;8(2):87. doi: 10.3390/gels8020087. Gels. 2022. PMID: 35200468 Free PMC article.

4

The Questionable Quality Profile of Food Supplements: The Case of Red Yeast Rice Marketed Products.

Vitiello A, Izzo L, Castaldo L, d'Angelo I, Ungaro F, Miro A, Ritieni A, Quaglia F. Vitiello A, et al. Among authors: ungaro f. Foods. 2023 May 25;12(11):2142. doi: 10.3390/foods12112142. Foods. 2023. PMID: 37297387 Free PMC article.

5

Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations.

Ungaro F, De Rosa G, Miro A, Quaglia F. Ungaro F, et al. J Pharm Biomed Anal. 2003 Feb 5;31(1):143-9. doi: 10.1016/s0731-7085(02)00571-x. J Pharm Biomed Anal. 2003. PMID: 12560058

6

How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system.

De Rosa G, Larobina D, Immacolata La Rotonda M, Musto P, Quaglia F, Ungaro F. De Rosa G, et al. Among authors: ungaro f. J Control Release. 2005 Jan 20;102(1):71-83. doi: 10.1016/j.jconrel.2004.09.030. J Control Release. 2005. PMID: 15653135

7

Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.

De Rosa G, Maiuri MC, Ungaro F, De Stefano D, Quaglia F, La Rotonda MI, Carnuccio R. De Rosa G, et al. Among authors: ungaro f. J Gene Med. 2005 Jun;7(6):771-81. doi: 10.1002/jgm.724. J Gene Med. 2005. PMID: 15702489

8

Microsphere-integrated collagen scaffolds for tissue engineering: effect of microsphere formulation and scaffold properties on protein release kinetics.

Ungaro F, Biondi M, d'Angelo I, Indolfi L, Quaglia F, Netti PA, La Rotonda MI. Ungaro F, et al. J Control Release. 2006 Jun 28;113(2):128-36. doi: 10.1016/j.jconrel.2006.04.011. Epub 2006 May 7. J Control Release. 2006. PMID: 16787679

9

Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs.

Ungaro F, De Rosa G, Miro A, Quaglia F, La Rotonda MI. Ungaro F, et al. Eur J Pharm Sci. 2006 Aug;28(5):423-32. doi: 10.1016/j.ejps.2006.05.005. Epub 2006 May 22. Eur J Pharm Sci. 2006. PMID: 16806857

10

Controlled drug delivery in tissue engineering.

Biondi M, Ungaro F, Quaglia F, Netti PA. Biondi M, et al. Among authors: ungaro f. Adv Drug Deliv Rev. 2008 Jan 14;60(2):229-42. doi: 10.1016/j.addr.2007.08.038. Epub 2007 Oct 11. Adv Drug Deliv Rev. 2008. PMID: 18031864 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

342 results

Search Page